Stifel Financial’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Stifel Financial's TVTX Position: Q3 2026 in Review
Stifel Financial reduced its Travere Therapeutics (TVTX) stake by 4.4% in Q3 2026, selling an estimated $29K and leaving 10,207 shares worth $601K. The position accounts for ﹤0.01% of the portfolio, ranked #2878.
Stifel Financial first reported a position in TVTX in Q4 2025 and has held it in 4 quarters since. The position peaked at $607K in Q2 2026. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Stifel Financial held 10,207 shares of Travere Therapeutics worth $601K as of Q3 2026.
- Stifel Financial sold 475 Travere Therapeutics shares in Q3 2026, an estimated $29K.
- Travere Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #2878 holding.
- Stifel Financial first reported a position in Travere Therapeutics in Q4 2025 and has held it in 4 quarters since.
- Stifel Financial's Travere Therapeutics position peaked at $607K in Q2 2026.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.